Growth Metrics

Dare Bioscience (DARE) Depreciation & Amortization (CF) (2016 - 2025)

Dare Bioscience's Depreciation & Amortization (CF) history spans 11 years, with the latest figure at $534395.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 8291.88% year-over-year to $534395.0; the TTM value through Dec 2025 reached $1.6 million, up 3761.75%, while the annual FY2025 figure was $1.6 million, 3761.75% up from the prior year.
  • Depreciation & Amortization (CF) reached $534395.0 in Q4 2025 per DARE's latest filing, up from $481906.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $534395.0 in Q4 2025 to a low of $3034.0 in Q3 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $88289.4, with a median of $9561.5 recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): tumbled 52.17% in 2022, then soared 8291.88% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $7047.0 in 2021, then skyrocketed by 50.73% to $10622.0 in 2022, then decreased by 6.04% to $9980.0 in 2023, then crashed by 36.19% to $6368.0 in 2024, then skyrocketed by 8291.88% to $534395.0 in 2025.
  • Per Business Quant, the three most recent readings for DARE's Depreciation & Amortization (CF) are $534395.0 (Q4 2025), $481906.0 (Q3 2025), and $460075.0 (Q2 2025).